By Ian Wishart
The Ministry of Health is paying thousands of dollars to schools who agree to push teenage girls into being vaccinated with Gardasil, the new cervical cancer inoculation.
A letter sent by the Ministry of Education to school principals this week states that “To recognize the role that schools play in the programme, the Ministry of Health will provide a one-off support payment to participating schools…the Ministry of Education will assist in the funding transfer to schools, by placing the Ministry of Health funds in participating schools’ accounts in April 2009, with the identifier, ‘HPV Payment’.”
The letter, published first on a major blogsite, discloses a base payment of between $200 and $300 per school depending on whether they have Year 8 classes, plus an additional $2.50 per female student eligible to receive the vaccine (years 8 to 13).
Some larger high schools could receive cash payments totaling several thousand dollars if they allow schools to be used to market and administer the vaccine to children.
The news comes just as a report on adverse reactions to Gardasil has been made available, which disclosed 29 deaths in teenage girls who received the Gardasil vaccine in the US. The study, based on reports provided to the US government’s Vaccine Adverse Events Reporting System (VAERS), was published by the National Vaccine Information Center, an anti-immunisation organisation in the US.
The study, which compared a cohort of girls who’d received the Gardasil vaccine, with a cohort who’d received a widely-used meningococcal vaccine known as Menactra, has thrown up some disturbing results.
“VAERS is a sentinel reporting system,” says the study, “designed to raise ‘red flags’ for unusual numbers of serious adverse events following receipt of a newly licensed vaccine.”
One red flag in 2005 was raised after five girls developed the debilitating Guillain Barre Syndrome after being injected with Menactra in one campaign. But it seems Gardasil has provoked even more serious reactions. Twenty five girls died soon after receiving the cervical cancer vaccine, compared with six deaths contemporaneous with Menactra. Nine girls suffered heart attacks after the cervical cancer jab, and two after Menactra. Sixteen teenage girls suffered strokes after Gardasil injections, and one on Menactra. Thirty four girls on the cervical cancer jab suffered thrombosis, compared to just one after Menactra, and a further 23 teenage girls were hospitalized with blood clots after their Gardasil injection while none of the Menactra teens had that reaction.
A staggering 544 American girls suffered seizures Schools bribed to market vaccines proximity to the cervical cancer injection, and while 158 given Menactra suffered seizures as well, doctors later discovered that 73 of those had also been given Gardasil.
Compared to Menactra,” says the study, “receipt Gardasil is associated with at least twice as many Emergency Room visit reports, four times more Death reports, five times more Did Not Recover reports and seven times more Disabled reports.
It is unusual for there to be such a big discrepancy between two vaccines used in similar populations involving serious and relatively rare life-threatening adverse events and autoimmune disorders such as death, blood clots, cardiac arrest, lupus, thrombosis, stroke and vasculitis,” says the study.
Fainting, which has been attributed by doctors health officials as ‘fear’ of needles in teenage girls is reported six times as often… after receipt Gardasil than Menactra, even though Menactra also given to girls in the same age group.
In pre-licensure clinical trials, Gardasil was only tested in fewer than 1200 girls, 16 years and younger. Through November 30, 2008, in girls 16 or younger, there were reports of 9 deaths, 3 blood clots, cardiac arrests, 9 cases of lupus, 6 strokes…after receipt of Gardasil.”
The National Vaccine Information Centre has also called on the US Congress to “investigate the fast-tracking of Gardasil vaccine without adequate long term safety studies in American pre-adolescent and teenage girls between ages 9 and 16 and the safety
efficacy of Gardasil vaccine in all age groups.”
Meanwhile the US Centers for Disease Control belatedly begun investigations into Gardasil after a 15 year old girl died this month from complications of what appears to be a particularly rapid and aggressive motor neurone disease (like physicist Stephen Hawking’s), which developed after she first received the Gardasil vaccine in 2007. Jenny Tetlock’s father, a psychology professor at UC Berkley, is now among a number of parents asking why, as vaccine maker Merck faces lawsuits over the dangers
of Gardasil – dangers the vaccine company denies. Several other teenage girls developed the same paralyzing illness after being vaccinated against cervical cancer, and Jenny’s parents suspect “it could be just the tip of the iceberg”. Jenny’s family
are holding her memorial service this weekend.
Part of the reason for the ‘tip of the iceberg’ claim i is that many adverse vaccine reactions, although treated by medics, are not reported to the VAERS centre, meaning that although VAERS can indicate problems, it can’t necessarily tell you how widespread
they are in relation to total vaccine doses. The type of illness that struck Jenny Tetlock, for example, should only strike one in five million girls, yet from a survey of their 30,000 website visitors the Tetlocks are aware of three verified cases. With only just over six million girls vaccinated in the US (three shots per child), the odds of three in a sample of 30,000 developing aggressive motor neurone disease naturally are very unlikely.
New Zealand’s Ministry of Health steers well clear of the Tetlock case but rejects generally claims that girls have died after receiving Gardasil shots:
“The NVIC reports that the vaccine has caused deaths in the US. These were rigorously investigated by the Centers for Disease Control who have not established
any causal links between the deaths and the vaccine,” says he Ministry’s Dr Greg Simmons, NZ’s Chief Advisor on Population Health. “ Their findings are publicly available (https://www.cdc.gov/vaccinesafety/) and support the ongoing availability of the vaccine.
“On their website, the US Centers for Disease Control [CDC] state that ‘As of December 31, 2008, there have been 32 US reports of death among females who have received the vaccine. Each of these deaths has been reviewed and there was not a common pattern to the deaths that would suggest they were caused by the vaccine. In cases where there was an autopsy, death certificate, or medical records, the cause of death was explained by factors other than the vaccine. Some reported causes of death received to date include illicit drug use, diabetes, viral illness, and heart failure’.”
Despite the assurance, the CDC’s statement fails to address why vastly more deaths have been reported in the wake of Gardasil injections than Menactra injections. If the deaths were all random and unrelated to the vaccines at all, then similar death rates should apply across all vaccines.
Instead, of the six million US girls vaccinated against Gardasil 32 have died soon after, whilst of the approximately ten million girls given Menactra shots, only six have died. Statistically, the Gardasil death rate appears to be highly significant.
Of the more than 10,000 adverse reports on Gardasil, NZ’s Ministry of Health says “94% of these considered minor such as injection site pain, nausea or dizziness.” The remaining six percent, or more than 600 cases, are implicitly acknowledged as medium to serious.
The Ministry of Health statement did not address specific allegations regarding blood clots, heart attacks or strokes, but made a general statement about the reality of side effects.
“US authorities, as well as health regulators around the world including Medsafe in New Zealand continue to monitor the adverse events reported in association with the vaccine and consider that the benefit – risk profile remains positive.
“Although Gardasil, as with any vaccine, has the potential to cause some adverse effects, the decision to vaccinate needs to be made on an individual basis keeping in mind the potential benefit of preventing cervical cancer being balanced against the potential risks of adverse effects. These potential adverse effects are discussed in the Consumer Medicine Information leaflet which can be found on the Medsafe website at: https://www.medsafe.govt.nz/Consumers/cmi/g/Gardasil.htm ”
On the allegation of ‘bribing’ schools, Dr Simmons says paying schools to help market vaccines to children has been done here before:
“Each school’s Board of Trustees was responsible for deciding if the immunisation programme could be delivered at their school. Schools have received support payments for allowing immunisation clinics to be provided on their premises before.”
For further information on adverse reactions linked to Gardasil, see https://www.newsinferno.com/archives/5267
Whistleblower talks to Alex Jones about the HPV vaccine. Listen to the other parts of this interview at this site also